Neoplasm Metastasis: all 3,564 studies
Page 7 of 36. Open to participants first (875), then studies with results posted, then the rest; newest registration first within each.
- Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver MetastasesRecruitingNCT05794971Phase 3
- Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver MetastasesRecruitingNCT05771025Not applicable
- Early or Delayed Intervention of Brain Radiotherapy Combined With Almonertinib in EGFR Mutated NSCLC With Brain MetastasesRecruitingNCT05768490Phase 3
- Ultrasound Radiomics for Predicting Breast Cancer and Axillary Lymph Node MetastasisNot yet recruitingNCT05768451
- (Neo)Adjuvant BRAF/MEK Inhibition in pN1c MelanomaRecruitingNCT05767879Phase 2
- A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaRecruitingNCT05755113Phase 2
- Proton Cranio-spinal Irradiation for Leptomeningeal MetastasisRecruitingNCT05746754Not applicable
- Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal MetastasesRecruitingNCT05742425Phase 2
- Efficacy and Safety of Apalutamide in Combination With 89Sr as Neoadjuvant Therapy in Prostate Cancer With ≤10 Bone MetastasesRecruitingNCT05740488Not applicable
- Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced CancerRecruitingNCT05735080Phase 1/2
- Spatiotemporal Stereotactic Body Radiation Therapy for the Treatment of Patients With Polymetastatic Solid TumorsRecruitingNCT05733949Early Phase 1
- TEAS for the Treatment of Pain in Bone Metastases of Lung CancerNot yet recruitingNCT05730972Not applicable
- Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaRecruitingNCT05726383Phase 2
- Prediction of Peritoneal Metastasis for Gastric Cancer Based on RadiomicsRecruitingNCT05722275
- Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC DetectionNot yet recruitingNCT05720559Phase 2
- A Study of PYX-201 in Advanced Solid TumorsRecruitingNCT05720117Phase 1
- A Study of ASP1002 in Adults for Treatment of Solid TumorsRecruitingNCT05719558Phase 1
- A Randomized Phase III Trial of Stereotactic Ablative Radiotherapy for Patients With Up to 10 Oligometastases and a Synchronous Primary Tumor.RecruitingNCT05717166Phase 3
- STUDY02001740;22SCH740: Estradiol For ER+ Advanced Breast Cancer (ESTHER)RecruitingNCT05716516Phase 2
- Combination Therapy in Cancers With Mutations in DNA Repair GenesRecruitingNCT05694715Phase 1
- Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid CancersRecruitingNCT05691517Phase 1
- Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and EffectivenessRecruitingNCT05691491Phase 1/2
- SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)RecruitingNCT05689619Not applicable
- Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid TumorsRecruitingNCT05687136Phase 1
- Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair GenesRecruitingNCT05687110Phase 1
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersRecruitingNCT05686226Phase 2
- Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based ApproachesRecruitingNCT05679518Not applicable
- Single-Cell Transcriptomics of the Peritoneal Microenvironment of Colorectal PCRecruitingNCT05676372
- Investigation of Profile-related Evidence Determining Individualized Cancer Therapy for Patients With Aggressive Malignancies and Poor PrognosesRecruitingNCT05674825Phase 1/2
- A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)RecruitingNCT05673928Phase 2
- Surgery With Extended (D3) Mesenterectomy for Small Bowel TumorsRecruitingNCT05670574Not applicable
- Primary Lesion Treatment for Bone MetastasesNot yet recruitingNCT05665790Not applicable
- Local Treatment for Bone MetastasesNot yet recruitingNCT05665439Not applicable
- Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant MelanomaNot yet recruitingNCT05664139Phase 2
- HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal MetastasisNot yet recruitingNCT05648487Phase 2
- Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain MetastasesRecruitingNCT05638425
- Spine Radiosurgery for Symptomatic Metastatic NeoplasmsRecruitingNCT05617716Phase 2
- FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3RecruitingNCT05614739Phase 1
- Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological MalignanciesNot yet recruitingNCT05612607Phase 4
- In Vivo Lung Perfusion (IVLP) for Colorectal Cancer Metastatic to LungRecruitingNCT05611034Phase 1
- A Study of ZEN003694 in People With Squamous Cell Lung CancerRecruitingNCT05607108Phase 2
- Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver MetastasesNot yet recruitingNCT05588297Phase 2
- Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAMLRecruitingNCT05584761Phase 1/2
- PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab DeruxtecanRecruitingNCT05573893
- A Ketogenic Diet as a Complementary Treatment on Patients With High-grade Gliomas and Brain MetastasesRecruitingNCT05564949Not applicable
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruitingNCT05564377Phase 2
- A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerRecruitingNCT05562791Phase 1
- Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid TumorsRecruitingNCT05544240Phase 1
- ONC201 and Atezolizumab in Obesity-Driven Endometrial CancerRecruitingNCT05542407Phase 1
- PSMA Response in Metastasized Hormone Sensitive Prostate Cancer - EnzalutamideRecruitingNCT05539300Not applicable
- UTD1 Combined With Capecitabine in Metastatic HER2-negative Breast Cancer Patients With Brain MetastasesRecruitingNCT05535413Phase 1/2
- Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsRecruitingNCT05533697Phase 1/2
- Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor RemovalRecruitingNCT05530759
- Phase 1b/2 Study of Liposomal Annamycin (L-Annamycin) in Subjects With Previously Treated Soft-Tissue Sarcomas (STS) With Pulmonary MetastasesRecruitingNCT05518526Phase 1/2
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05518253Phase 1
- Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAMLRecruitingNCT05513131Phase 2
- Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III TrialRecruitingNCT05508464Not applicable
- Post Operative RT for Limited Spine MetastasesRecruitingNCT05495399Not applicable
- Treatment of Metastatic Cancer in Terminally Diagnosed PatientsAvailableNCT05491928
- Integrative Omics Analysis for Colorectal Cancer and MetastasisRecruitingNCT05482529
- Effect of Zoledronic Acid Treatment on Bone-related Events in Breast Cancer Patients With Bone Metastases: a Prospective, Multicenter, Real-world StudyNot yet recruitingNCT05480189
- Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION)RecruitingNCT05475171Phase 2
- Surufatinib and Sintilimab in Combination With Capecitabine for Metastatic Adenocarcinoma of Small Intestine or Appendix CarcinomaRecruitingNCT05472948Phase 2
- A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-TRecruitingNCT05468190Phase 1
- Efficacy of Sr-89 for Differentiated Thyroid Cancer With Bone MetastasesNot yet recruitingNCT05466812Phase 4
- A Study of BL-M07D1 in Patients With Locally Advanced or Metastatic HER2-Positive/Negative Breast Cancer and Other Solid TumorsRecruitingNCT05461768Phase 1
- Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)RecruitingNCT05431270Phase 1/2
- The DRAGON 2 TrialRecruitingNCT05428735Not applicable
- Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.RecruitingNCT05422911Phase 2
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05420545Phase 1
- Clinical Study of CD70-targeted CAR-T Therapy for Advanced/Advanced Renal CancerRecruitingNCT05420519Phase 1
- Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone MetasRecruitingNCT05419518Phase 2
- Stereotactic Multiple Fraction Radiotherapy for Non-spine Bone MetastasesRecruitingNCT05406063Not applicable
- Diagnosis of Metastatic Tumors on 68Ga-FAPI PET-CT and Radioligand Therapy with 177Lu-EB-FAPIRecruitingNCT05400967Early Phase 1
- Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsRecruitingNCT05394103Phase 1/2
- A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)RecruitingNCT05384626Phase 1/2
- A Study of ASP3082 in Adults With Advanced Solid TumorsRecruitingNCT05382559Phase 1
- Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASRecruitingNCT05379985Phase 1/2
- The CyberChallenge Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?RecruitingNCT05378633Not applicable
- Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid TumorsRecruitingNCT05372640Phase 1
- Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 GeneRecruitingNCT05372614Phase 1
- Study to Evaluate CD8 PET Imaging as a Marker of Immune Response to Stereotactic Body Radiation Therapy (ELIXR)RecruitingNCT05371132Phase 1
- Study to Assess the Safety and Preliminary Efficacy of STI-1386 Oncolytic Virus in Relapsed or Refractory Solid TumorsNot yet recruitingNCT05361954Phase 1
- A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal MetastasisNot yet recruitingNCT05359393Phase 2
- Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver MetastasisNot yet recruitingNCT05354674
- A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY).RecruitingNCT05354596Not applicable
- Preoperative Systemic Therapy for Colorectal Cancer Peritoneal MetastasesNot yet recruitingNCT05353582Phase 2
- Detection of Peritoneal Metastasis of Gastric Cancer by Liquid Biopsy in Peripheral Blood: A Prospective StudyRecruitingNCT05347524
- Improving Therapeutic Ratio With Hypo Fractionated Stereotactic Radiotherapy for Brain MetastasesRecruitingNCT05346367Not applicable
- Study of PAT in Patients With Solid Tumor CancersRecruitingNCT05338658Phase 1
- Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver MetastasesRecruitingNCT05325528Phase 2/3
- Tumor Microenvironment Analysis of Prostate Cancer MetastasisRecruitingNCT05304858
- COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO StudyRecruitingNCT05301881Phase 2
- Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic CancersRecruitingNCT05296564Phase 1/2
- Venetoclax Basket Trial for High Risk Hematologic MalignanciesRecruitingNCT05292664Phase 1
- Evaluation of Tumour Growth and Oncological Treatment in Patients With CRLM Using Zebra Fish Embryo ModelRecruitingNCT05289076Phase 1/2
- Study of Orellanine in Metastatic Clear-Cell or Papillary Renal Cell CarcinomaRecruitingNCT05287945Phase 1/2
- Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing TumorsRecruitingNCT05283330Phase 1
- Implementing Precision Medicine in cOmmunity HospiTALsRecruitingNCT05283044Not applicable
- Recovery Rate in Secondary HypothyroidismRecruitingNCT05276856